Establishing and evaluation of a polymerase chain reaction for the detection of Echinococcus multilocularis in human tissue.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
06
07
2020
accepted:
19
01
2021
entrez:
25
2
2021
pubmed:
26
2
2021
medline:
23
6
2021
Statut:
epublish
Résumé
Alveolar echinococcosis (AE) is caused by metacestode larva of the tapeworm Echinococcus multilocularis. AE diagnostics currently rely on imaging techniques supported by serology, but unequivocal detection of AE is difficult. Although polymerase chain reaction (PCR)-based methods to detect tapeworm DNA in biopsies have been suggested for several species, no validated protocol adhering to accepted guidelines has so far been presented for AE diagnostics. We herein established a PCR protocol for metacestode biopsies and technically evaluated the method using isolated parasite DNA and cells, biopsies of clinically relevant material, and formalin fixed paraffin-embedded (FFPE) human tissue blocks. We compared the results with an immunochemical (IHC) approach using the monoclonal antibody Em2G11 specific for the antigen Em2 of E. mulitlocularis. Based on tapeworm 12S rDNA sequences we established and validated a PCR protocol for robust detection of as little as 50 parasite cells per specimen and report 127 cases of positive identification of Echinococcus species in samples from humans and animals. For further validation, we analyzed 45 liver, heart, brain, and soft tissue samples as well as cytological probes of aspirates of FFPE-material from 18 patients with clinically confirmed AE. Of each patient we analyzed (i) fully viable lesions with laminated layer; (ii) tissue with mAbEm2G11-positive small particles of E. multilocularis (spems); (iii) mAbEm2G11-negative tissue adjacent to the main lesion; and (iv) lymph node tissue with mAbEm2G11-positive spems. To identify the areas for the PCR-based approach, we performed IHC-staining with the monoclonal antibody Em2G11. Micro-dissected tissue of these areas was then used for PCR-analysis. 9 of 15 analyzed samples with viable E. multilocularis lesions with laminated layer were positive by PCR. Of this group, all samples preserved for less than 6 years (6/6) were tested positive. 11 of 15 samples of spems and 7 of 9 samples of the control group mAbEm2G11-negative tissue were negative by PCR. We further show that all probes from lymph nodes with spems are PCR negative. We present a sensitive PCR method for the detection of E. multilocularis in human tissue, particularly in fresh biopsy material and tissue blocks stored for less than 5 years. While the diagnostic sensitivity of material containing only spems was higher using IHC, PCR detection was possible in IHC negative liver tissue and in patients with negative serology. Our results support the view that spems do not contain parasitic DNA or viable cells of the parasite. spems thus most probably do not directly contribute to metastasis formation during AE.
Sections du résumé
BACKGROUND
Alveolar echinococcosis (AE) is caused by metacestode larva of the tapeworm Echinococcus multilocularis. AE diagnostics currently rely on imaging techniques supported by serology, but unequivocal detection of AE is difficult. Although polymerase chain reaction (PCR)-based methods to detect tapeworm DNA in biopsies have been suggested for several species, no validated protocol adhering to accepted guidelines has so far been presented for AE diagnostics. We herein established a PCR protocol for metacestode biopsies and technically evaluated the method using isolated parasite DNA and cells, biopsies of clinically relevant material, and formalin fixed paraffin-embedded (FFPE) human tissue blocks. We compared the results with an immunochemical (IHC) approach using the monoclonal antibody Em2G11 specific for the antigen Em2 of E. mulitlocularis.
METHODOLOGY/PRINCIPAL FINDINGS
Based on tapeworm 12S rDNA sequences we established and validated a PCR protocol for robust detection of as little as 50 parasite cells per specimen and report 127 cases of positive identification of Echinococcus species in samples from humans and animals. For further validation, we analyzed 45 liver, heart, brain, and soft tissue samples as well as cytological probes of aspirates of FFPE-material from 18 patients with clinically confirmed AE. Of each patient we analyzed (i) fully viable lesions with laminated layer; (ii) tissue with mAbEm2G11-positive small particles of E. multilocularis (spems); (iii) mAbEm2G11-negative tissue adjacent to the main lesion; and (iv) lymph node tissue with mAbEm2G11-positive spems. To identify the areas for the PCR-based approach, we performed IHC-staining with the monoclonal antibody Em2G11. Micro-dissected tissue of these areas was then used for PCR-analysis. 9 of 15 analyzed samples with viable E. multilocularis lesions with laminated layer were positive by PCR. Of this group, all samples preserved for less than 6 years (6/6) were tested positive. 11 of 15 samples of spems and 7 of 9 samples of the control group mAbEm2G11-negative tissue were negative by PCR. We further show that all probes from lymph nodes with spems are PCR negative.
CONCLUSIONS/SIGNIFICANCE
We present a sensitive PCR method for the detection of E. multilocularis in human tissue, particularly in fresh biopsy material and tissue blocks stored for less than 5 years. While the diagnostic sensitivity of material containing only spems was higher using IHC, PCR detection was possible in IHC negative liver tissue and in patients with negative serology. Our results support the view that spems do not contain parasitic DNA or viable cells of the parasite. spems thus most probably do not directly contribute to metastasis formation during AE.
Identifiants
pubmed: 33630840
doi: 10.1371/journal.pntd.0009155
pii: PNTD-D-20-01219
pmc: PMC7906421
doi:
Substances chimiques
Antibodies, Monoclonal
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009155Subventions
Organisme : Wellcome Trust
ID : 107475/Z/15/Z
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JMM Case Rep. 2017 Jun 8;4(6):e005097
pubmed: 29026624
Langenbecks Arch Surg. 2009 Jul;394(4):699-704
pubmed: 19373487
Trends Parasitol. 2011 Jun;27(6):264-73
pubmed: 21376669
BMC Biol. 2016 Mar 04;14:10
pubmed: 26941070
PLoS One. 2019 Oct 29;14(10):e0224501
pubmed: 31661532
J Clin Microbiol. 2013 Sep;51(9):3151-3
pubmed: 23824768
Food Waterborne Parasitol. 2019 Mar 14;15:e00040
pubmed: 32095613
PLoS Negl Trop Dis. 2017 May 25;11(5):e0005636
pubmed: 28542546
PLoS Negl Trop Dis. 2010 Jun 22;4(6):e722
pubmed: 20582310
Adv Parasitol. 2017;96:159-257
pubmed: 28212789
Am J Trop Med Hyg. 2007 Sep;77(3):504-6
pubmed: 17827368
Adv Parasitol. 2017;95:147-212
pubmed: 28131363
Am J Trop Med Hyg. 2009 May;80(5):792-7
pubmed: 19407126
PLoS Negl Trop Dis. 2012;6(10):e1877
pubmed: 23145198
Nature. 2013 Apr 04;496(7443):57-63
pubmed: 23485966
Mol Biochem Parasitol. 2010 Nov;174(1):83-7
pubmed: 20637246
Adv Parasitol. 2017;95:315-493
pubmed: 28131365
J Helminthol. 2016 Jul;90(4):417-21
pubmed: 26190231
Clin Microbiol Rev. 2010 Jul;23(3):550-76
pubmed: 20610823
Am J Surg Pathol. 2020 Jan;44(1):43-54
pubmed: 31567204
Eur J Hum Genet. 2010 Dec;18(12):1276-88
pubmed: 20664632
Int J Parasitol. 2008 Jul;38(8-9):1065-71
pubmed: 18177654
Parasitology. 1991 Aug;103 Pt 1:41-9
pubmed: 1945524
Infect Dis Poverty. 2019 Jul 30;8(1):68
pubmed: 31362789
J Biomed Biotechnol. 2010;2010:923193
pubmed: 20339517
Clin Infect Dis. 2003 Oct 15;37(8):e121-5
pubmed: 14523787
Virchows Arch. 2012 Feb;460(2):131-40
pubmed: 22270699
Exp Parasitol. 2015 Nov;158:23-30
pubmed: 25816974
J Mol Evol. 1999 May;48(5):586-96
pubmed: 10198124
Clin Vaccine Immunol. 2008 Nov;15(11):1633-7
pubmed: 18799646
Acta Trop. 2010 Apr;114(1):1-16
pubmed: 19931502
Trends Parasitol. 2011 May;27(5):204-13
pubmed: 21257348
Trop Med Infect Dis. 2017 Aug 05;2(3):
pubmed: 30270893
Emerg Infect Dis. 2006 Feb;12(2):296-303
pubmed: 16494758
Adv Parasitol. 2017;95:65-109
pubmed: 28131366
Langenbecks Arch Surg. 2018 Aug;403(5):655-662
pubmed: 29909530
BMC Infect Dis. 2020 Apr 3;20(1):262
pubmed: 32245373
Evodevo. 2014 Mar 06;5(1):10
pubmed: 24602211
Methods Mol Biol. 2009;470:245-62
pubmed: 19089387
J Clin Virol. 2013 Mar;56(3):260-70
pubmed: 23246357
Parasitol Res. 2011 Aug;109(2):411-6
pubmed: 21286751
Adv Parasitol. 2017;96:55-158
pubmed: 28212791
Int J Parasitol. 2017 Sep;47(10-11):675-686
pubmed: 28668323
Sci Rep. 2016 Dec 14;6:39204
pubmed: 27966637
Adv Parasitol. 2017;96:259-369
pubmed: 28212790
Vector Borne Zoonotic Dis. 2020 Aug;20(8):593-602
pubmed: 32251614
J Clin Microbiol. 1993 Dec;31(12):3211-5
pubmed: 8308113